v3.25.3
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' (DEFICIT) EQUITY (UNAUDITED) - USD ($)
Common shares [Member]
Shares to be issued [Member]
Additional paid-in capital [Member]
Accumulated deficit [Member]
Accumulated Other Comprehensive Income [Member]
Non-Controlling Interest [Member]
Total
Beginning Balance at Dec. 31, 2023 $ 18,761,250 $ 0 $ 98,585 $ (17,748,387) $ 0 $ 0 $ 1,111,448
Beginning Balance (Shares) at Dec. 31, 2023 8,076,673 0          
Share-based compensation $ 0 $ 0 35,953       35,953
Net loss and comprehensive loss for the period 0 0   (1,707,358) 0 0 (1,707,358)
Ending Balance at Mar. 31, 2024 $ 18,761,250 $ 0 134,538 (19,455,745) 0 0 (559,957)
Ending Balance (Shares) at Mar. 31, 2024 8,076,673 0          
Beginning Balance at Dec. 31, 2023 $ 18,761,250 $ 0 98,585 (17,748,387) 0 0 1,111,448
Beginning Balance (Shares) at Dec. 31, 2023 8,076,673 0          
Deemed dividend on warrant inducement             0
Net loss and comprehensive loss for the period             (7,618,964)
Ending Balance at Sep. 30, 2024 $ 29,442,212 $ 0 719,980 (25,367,351) 0 0 4,794,841
Ending Balance (Shares) at Sep. 30, 2024 10,846,721 0          
Beginning Balance at Mar. 31, 2024 $ 18,761,250 $ 0 134,538 (19,455,745) 0 0 (559,957)
Beginning Balance (Shares) at Mar. 31, 2024 8,076,673 0          
Conversion of debt $ 5,210,962 $ 0 0 0     5,210,962
Conversion of debt (Shares) 1,308,798            
Issuance of common shares $ 5,470,000 0 0 0     5,470,000
Issuance of common shares (Shares) 1,461,250            
Share-based compensation $ 0 0 585,442       585,442
Net loss and comprehensive loss for the period 0 0   (3,632,859) 0 0 (3,632,859)
Ending Balance at Jun. 30, 2024 $ 29,442,212 $ 0 719,980 (23,088,604) 0 0 7,073,588
Ending Balance (Shares) at Jun. 30, 2024 10,846,721 0          
Deemed dividend on warrant inducement             0
Net loss and comprehensive loss for the period $ 0 $ 0 0 (2,278,747) 0 0 (2,278,747)
Ending Balance at Sep. 30, 2024 $ 29,442,212 $ 0 719,980 (25,367,351) 0 0 4,794,841
Ending Balance (Shares) at Sep. 30, 2024 10,846,721 0          
Beginning Balance at Dec. 31, 2024 $ 30,518,195   1,520,412 (28,903,903)     $ 3,134,704
Beginning Balance (Shares) at Dec. 31, 2024 11,816,721 0         11,816,721
Issuance of common shares and warrants in connection with Regulation A, net of issuance costs $ 2,076,507 $ 0 1,612,474 0 0 0 $ 3,688,981
Issuance of common shares and warrants in connection with Regulation A, net of issuance costs (Shares) 1,490,000            
Issuance of common shares in connection with SEPA offering costs $ 300,000 0 0 0 0 0 300,000
Issuance of common shares in connection with SEPA offering costs (Shares) 105,840            
Issuance of common shares upon exercise of stock warrants $ 14,000 0 0 0 0 0 14,000
Issuance of common shares upon exercise of stock warrants (Shares) 5,000            
Share-based compensation $ 0 0 112,277 0 0 0 112,277
Net loss and comprehensive loss for the period 0 0 0 (5,102,408) 0 0 (5,102,408)
Ending Balance at Mar. 31, 2025 $ 32,908,702 $ 0 3,245,163 (34,006,311) 0 0 2,147,554
Ending Balance (Shares) at Mar. 31, 2025 13,417,561 0          
Beginning Balance at Dec. 31, 2024 $ 30,518,195   1,520,412 (28,903,903)     $ 3,134,704
Beginning Balance (Shares) at Dec. 31, 2024 11,816,721 0         11,816,721
Issuance of common shares upon exercise of stock options (Shares)             145,000
Deemed dividend on warrant inducement             $ (4,954,518)
Net loss and comprehensive loss for the period             (27,259,804)
Ending Balance at Sep. 30, 2025 $ 48,479,031 $ 313,934 6,449,863 (56,163,630) 10,676 105,236 $ (804,890)
Ending Balance (Shares) at Sep. 30, 2025 20,971,122 205,980         20,971,122
Beginning Balance at Mar. 31, 2025 $ 32,908,702 $ 0 3,245,163 (34,006,311) 0 0 $ 2,147,554
Beginning Balance (Shares) at Mar. 31, 2025 13,417,561 0          
Issuance of common shares and warrants in connection with equity financing $ 3,961,899 $ 0 2,234,495 0 0 0 6,196,394
Issuance of common shares and warrants in connection with equity financing (Shares) 2,260,000            
Issuance of common shares upon exercise of stock warrants $ 963,398 0 0 0 0 0 963,398
Issuance of common shares upon exercise of stock warrants (Shares) 258,705            
Share-based compensation     117,448       117,448
Net loss and comprehensive loss for the period $ 0 0 0 (6,176,084) 0 0 (6,176,084)
Ending Balance at Jun. 30, 2025 $ 37,833,999   5,597,106 (40,182,395)     3,248,710
Ending Balance (Shares) at Jun. 30, 2025 15,936,266            
Issuance of common shares in connection with SEPA offering costs $ 5,254,726   0 0 0 0 5,254,726
Issuance of common shares in connection with SEPA offering costs (Shares) 2,152,672            
Issuance of common shares upon exercise of stock warrants $ 3,752,000 0 0 0 0 0 3,752,000
Issuance of common shares upon exercise of stock warrants (Shares) 1,340,000            
Issuance of common shares upon exercise of stock options $ 162,400 0 0 0 0 0 162,400
Issuance of common shares upon exercise of stock options (Shares) 145,000            
Issuance of common shares for asset acquisition $ 2,129,410 $ 313,934 0 0 0 105,161 2,548,505
Issuance of common shares for asset acquisition (Shares) 1,397,184 205,980          
Share issuance costs $ (653,504)           (653,504)
Share-based compensation 0 $ 0 852,757 0 0 0 852,757
Warrants issued under warrant inducement     4,954,518       4,954,518
Deemed dividend on warrant inducement     (4,954,518)       (4,954,518)
Net loss and comprehensive loss for the period       (15,981,235)   (77) (15,981,312)
Other comprehensive income for the period 0 0 0 0 10,676 152 10,828
Ending Balance at Sep. 30, 2025 $ 48,479,031 $ 313,934 $ 6,449,863 $ (56,163,630) $ 10,676 $ 105,236 $ (804,890)
Ending Balance (Shares) at Sep. 30, 2025 20,971,122 205,980         20,971,122